OVIT Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.30 - $0.30
Previous CloseN/A
Volume10.00K
Average Volume (3M)0.00
Market Cap
$2.36K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-101.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding23,559,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
OVIT FAQ
What was OncoVista Innovative Therapies Inc’s price range in the past 12 months?
OncoVista Innovative Therapies Inc lowest stock price was $0.30 and its highest was $0.30 in the past 12 months.
What is OncoVista Innovative Therapies Inc’s market cap?
OncoVista Innovative Therapies Inc’s market cap is $2.36K.
When is OncoVista Innovative Therapies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OncoVista Innovative Therapies Inc’s earnings last quarter?
Currently, no data Available
Is OncoVista Innovative Therapies Inc overvalued?
According to Wall Street analysts OncoVista Innovative Therapies Inc’s price is currently Overvalued.
Does OncoVista Innovative Therapies Inc pay dividends?
OncoVista Innovative Therapies Inc does not currently pay dividends.
What is OncoVista Innovative Therapies Inc’s EPS estimate?
OncoVista Innovative Therapies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoVista Innovative Therapies Inc have?
OncoVista Innovative Therapies Inc has 23,559,000 shares outstanding.
What happened to OncoVista Innovative Therapies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of OncoVista Innovative Therapies Inc?
Currently, no hedge funds are holding shares in OVIT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OncoVista Innovative Therapies Inc
OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The firm produces drug discovery, registration strategies, and emerging technologies. Its products include Cordycepin and L-Nucleoside Conjugate. The company was founded on January 8, 1999 and is headquartered in San Antonio, TX.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
7.49% Other Institutional Investors
92.51% Public Companies and
Individual Investors